Characterization of Pyrrolidinyl-hexahydro-pyranopiperazines as a Novel Kappa Opioid Receptor Agonist Scaffold | ACS Chemical Neuroscience
Κ-opioid receptor - an overview | ScienceDirect Topics
Opioid Receptor | kappa, mu Opioid Receptor
κ-opioid receptor - Wikipedia
Kappa Opiate Receptor Agonist - an overview | ScienceDirect Topics
Opioids in cancer: The κ‑opioid receptor (Review)
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
Antagonists of the kappa opioid receptor - ScienceDirect
The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence - Biological Psychiatry
Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling
Molecules | Free Full-Text | Antipruritic Effect of Nalbuphine, a Kappa Opioid Receptor Agonist, in Mice: A Pan Antipruritic
κ-Opioid Receptor (KOP) | 7TM Antibodies
Table II from Systemic kappa opioid receptor agonists in the treatment of chronic pruritus: a literature review. | Semantic Scholar
Mu Agonist Opioids and Kappa Opioids | Download Table
Untangling the complexity of opioid receptor function | Neuropsychopharmacology
Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation | Scientific Reports
Innovation – Cara Therapeutics
κ-opioid receptor - Wikipedia
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
BRL 52537 hydrochloride, kappa-opioid agonist (CAS 112282-24-3) (ab120669)
Nalfurafine, a G-Protein–Biased KOR (Kappa Opioid Receptor) Agonist, Enhances the Diuretic Response and Limits Electrolyte Losses to Standard-of-Care Diuretics | Hypertension
Effects of Kappa Opioid Agonists on Cocaine- and Food-Maintained Responding by Rhesus Monkeys | Journal of Pharmacology and Experimental Therapeutics
Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation | Scientific Reports
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Understanding opioids in veterinary medicine
